Methylphenidate
Showing 1 - 25 of 585
Methylphenidate Treatment in ADHD
Not yet recruiting
- Methylphenidate
- Metabolomics
- methylphenidate
- (no location specified)
Oct 6, 2023
Alcohol Use Disorder, ADHD Trial (Methylphenidate Pill)
Not yet recruiting
- Alcohol Use Disorder
- Attention Deficit Hyperactivity Disorder
- Methylphenidate Pill
- (no location specified)
Sep 26, 2023
ADHD Trial in Baltimore (Methylphenidate, Placebo)
Not yet recruiting
- ADHD
- Methylphenidate
- Placebo
-
Baltimore, MarylandJohns Hopkins School of Medicine
Oct 5, 2023
Substance Use Disorder, Cocaine Use Disorder Trial in New York (Methylphenidate, Memory reconsolidation, Placebo)
Recruiting
- Substance Use Disorder
- Cocaine Use Disorder
- Methylphenidate
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 28, 2023
Adult ADHD, Adult-onset ADHD With Mood Disorder Trial in Strasbourg (Placebo, Methylphenidate immediate release 25mg)
Not yet recruiting
- Adult ADHD
- Adult-onset ADHD With Mood Disorder
- Placebo
- Methylphenidate immediate release 25mg
-
Strasbourg, FranceService de Psychiatrie 2, Hôpitaux Universitaires de Strasbourg
Apr 14, 2023
Attention Deficit Disorder With Hyperactivity, Diabetes, Type 1 Trial (parental training in behavior management,
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Diabetes Mellitus, Type 1
- parental training in behavior management
- +2 more
- (no location specified)
Jul 19, 2023
PTSD (PTSD) Trial in Tuscaloosa, Seattle (Methylphenidate, Placebo)
Not yet recruiting
- Posttraumatic Stress Disorder (PTSD)
- Methylphenidate
- Placebo
-
Tuscaloosa, Alabama
- +1 more
Mar 8, 2023
Parkinson Disease, Apathy Trial (Psychosocial intervention, Methylphenidate)
Not yet recruiting
- Parkinson Disease
- Apathy
- Psychosocial intervention
- Methylphenidate
- (no location specified)
Dec 28, 2022
Mechanism of Action of Methylphenidate in ADHD
Not yet recruiting
- Attention Deficit Hyperactivity Disorder
- Methylphenidate
- (no location specified)
Oct 26, 2022
ADHD, ADHD Trial in Irvine (Methylphenidate Hydrochloride Extended Release Capsules, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- ADHD
- Methylphenidate Hydrochloride Extended Release Capsule
- Placebo
-
Irvine, CaliforniaUniversity of California, Irvine/Child Development Center
Nov 16, 2022
Pain Trial in Chicago (Methylphenidate, Placebo)
Recruiting
- Pain
- Methylphenidate
- Placebo
-
Chicago, IllinoisNorthwestern University
Dec 30, 2022
Schizophrenia Schizoaffective Trial (Apo-Methylphenidate ER)
Recruiting
- Schizophrenia Schizoaffective
- Apo-Methylphenidate ER
-
Ottawa, Ontario, CanadaRoyal Ottawa Mental Health Centre
Oct 31, 2022
Adhd Trial (prolong-release methylphenidate)
Not yet recruiting
- Adhd
- prolong-release methylphenidate
- (no location specified)
Jun 5, 2022
PTSD Trial in Haifa, Netanya (Methylphenidate, Reboxetine, Placebo)
Recruiting
- Posttraumatic Stress Disorder
- Methylphenidate
- +2 more
-
Haifa, Israel
- +1 more
Nov 20, 2022
Alcohol Use Disorder Trial in Lexington (Alcohol, Placebos, Duloxetine)
Recruiting
- Alcohol Use Disorder
- Alcohol
- +3 more
-
Lexington, KentuckyUniversity of Kentucky
Sep 23, 2022
Healthy Volunteers Trial in Lille (Methylphenidate, Placebo, CogniPlus software)
Recruiting
- Healthy Volunteers
- Methylphenidate
- +3 more
-
Lille, FranceHôpital Roger Salengro, CHU
Aug 16, 2022
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,
Active, not recruiting
- Advanced Malignant Neoplasm
- +2 more
- Laboratory Biomarker Analysis
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Irritable Mood, ADHD Trial in Taipei (Methylphenidate, aripiprazole, and combination)
Completed
- Irritable Mood
- ADHD
- Methylphenidate, aripiprazole, and combination
-
Taipei, TaiwanTri-Service General Hospital, National Defense Medical Center
Aug 4, 2023
Prostate Carcinoma Trial in Houston (behavioral, drug, other)
Recruiting
- Prostate Carcinoma
- Exercise Intervention
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
ADHD - Combined Type Trial in Baltimore (Methylphenidate, Placebo)
Recruiting
- ADHD - Combined Type
- Methylphenidate
- Placebo
-
Baltimore, MarylandJohns Hopkins School of Medicine
May 12, 2022
Childhood Apraxia of Speech Trial in Parkville (Methylphenidate Hydrochloride, Placebo)
Recruiting
- Childhood Apraxia of Speech
- Methylphenidate Hydrochloride
- Placebo
-
Parkville, Victoria, AustraliaMurdoch Children's Research Institute
May 4, 2022
Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)
Recruiting
- Healthy
- Psilocybin
- +2 more
-
Zürich, SwitzerlandPsychiatrische Universitätsklinik Zürich
Oct 3, 2023
Attention Deficit/Hyperactivity Disorder Combined Type, ADHD Predominantly Inattentive Type, ADHD Predominantly Hyperactivity
Recruiting
- Attention Deficit/Hyperactivity Disorder Combined Type
- +3 more
- Methylphenidate- Ritalin IR (Immediate Release)
-
Ramat-Gan, IsraelADHD Medical Clinic, Child and Adolescent Psychiatry Unit, Sheba
May 16, 2022
Normal Physiology Trial run by the NIAAA (Oral Methylphenidate followed by IV , Oral followed by IV Methylphenidate, Oral
Enrolling by invitation
- Normal Physiology
- Oral Methylphenidate followed by IV placebo
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Fatigue Trial in Houston (Methylphenidate, Fatigue Evaluations)
Completed
- Fatigue
- Methylphenidate
- Fatigue Evaluations
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 3, 2022